{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:22:40Z","timestamp":1767054160838,"version":"3.48.0"},"reference-count":19,"publisher":"Georg Thieme Verlag KG","issue":"04","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP Rep"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Small-cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare, aggressive, and highly fatal gynecologic malignancy with few treatment guidelines offered in nonpregnant patients.<\/jats:p>\n                  <jats:p>A 32-year-old woman presented for initial prenatal care at 9 weeks and her dating ultrasound was notable for a large complex adnexal mass. Magnetic resonance imaging performed 2 weeks later revealed accelerated interval growth with possible malignant etiology. She underwent surgical evaluation with salpingo-oophorectomy. Pathology noted signature features of SCCOHT. The patient desired expectant management and declined termination of pregnancy or chemotherapy. Four weeks later, she developed severe abdominal pain, nausea, and vomiting, and she was diagnosed with extensive metastatic disease. After multidisciplinary and multi-institutional counseling, she elected for continuation of her pregnancy and 6-agent chemotherapy including Vinblastine, Cisplatin, Cyclophosphamide, Bleomycin, Doxorubicin, Etoposide (VPCBAE) with close antepartum surveillance. The patient completed multiple rounds of chemotherapy and subsequently delivered via primary cesarean at 272\/7 weeks due to maternal sepsis and nonreassuring fetal status. Maternal and neonatal death occurred approximately 1-week postpartum.<\/jats:p>\n                  <jats:p>This is the first known case of SCCOHT in which the pregnancy was continued through an aggressive chemotherapy regimen.<\/jats:p>","DOI":"10.1055\/a-2764-3698","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:09:53Z","timestamp":1765498193000},"page":"e175-e180","source":"Crossref","is-referenced-by-count":0,"title":["Aggressive Chemotherapy and Antepartum Management of Small-Cell Carcinoma of the Ovary of Hypercalcemic Type: A Novel Case Report with Ethical and Medical Decision-Making Consideration"],"prefix":"10.1055","volume":"15","author":[{"given":"Hind N.","family":"Moussa","sequence":"additional","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Cincinnati, Cincinnati, Ohio, United States"},{"name":"Department of Maternal Fetal Medicine, Maternal Fetal Medicine, Kettering Health, Kettering, Ohio, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6249-1034","authenticated-orcid":false,"given":"Dana","family":"Rector","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Toledo and ProMedica Toledo Hospital, Toledo, Ohio, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wesley","family":"Gherman","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, TriHealth, Cincinnati, Ohio, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Shuffle","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Toledo and ProMedica Toledo Hospital, Toledo, Ohio, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1441-6627","authenticated-orcid":false,"given":"Robert","family":"Fresch","sequence":"additional","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Cincinnati, Cincinnati, Ohio, United States"},{"name":"Department of Maternal Fetal Medicine, Maternal Fetal Medicine, Kettering Health, Kettering, Ohio, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Reid","sequence":"additional","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Cincinnati, Cincinnati, Ohio, United States"},{"name":"Department of Maternal Fetal Medicine, Maternal Fetal Medicine, Kettering Health, Kettering, Ohio, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"11","key":"ref1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJMcpc1000272","article-title":"Case records of the Massachusetts General Hospital. Case 8-2010. A 22-year-old woman with hypercalcemia and a pelvic mass","volume":"362","author":"R H Young","year":"2010","journal-title":"N Engl J Med"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/1097-0142(19820101)49:1<188::AID-CNCR2820490137>3.0.CO;2-D","article-title":"Small cell carcinoma of the ovary with hypercalcemia: a report of eleven cases","volume":"49","author":"G R Dickersin","year":"1982","journal-title":"Cancer"},{"issue":"03","key":"ref3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ygyno.2016.03.013","article-title":"The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type","volume":"141","author":"L Witkowski","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"05","key":"ref4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng.2922","article-title":"Recurrent SMARCA4 mutations in small cell carcinoma of the ovary","volume":"46","author":"P Jelinic","year":"2014","journal-title":"Nat Genet"},{"issue":"05","key":"ref5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ng.2928","article-title":"Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4","volume":"46","author":"P Ramos","year":"2014","journal-title":"Nat Genet"},{"issue":"05","key":"ref6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ng.2931","article-title":"Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type","volume":"46","author":"L Witkowski","year":"2014","journal-title":"Nat Genet"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.path.2016.01.005","article-title":"Small-cell carcinoma of the ovary of hypercalcemic type (malignant rhabdoid tumor of the ovary): a review with recent developments on pathogenesis","volume":"9","author":"L Witkowski","year":"2016","journal-title":"Surg Pathol Clin"},{"issue":"15","key":"ref8","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1158\/1078-0432.CCR-19-3797","article-title":"Small-cell carcinoma of the ovary, hypercalcemic type-genetics, new treatment targets, and current management guidelines","volume":"26","author":"M Tischkowitz","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2015.11.004","article-title":"Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): a review of 47 cases","volume":"140","author":"D Callegaro-Filho","year":"2016","journal-title":"Gynecol Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(11)61348-2","article-title":"Haematological cancers in pregnancy","volume":"379","author":"B Brenner","year":"2012","journal-title":"Lancet"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/annonc\/mdh009","article-title":"Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients","volume":"15","author":"N Germann","year":"2004","journal-title":"Ann Oncol"},{"issue":"08","key":"ref19","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/IGC.0b013e3181a83ea2","article-title":"Aggressive small cell carcinoma of the ovary, hypercalcemic type with hypercalcemia in pregnancy, treated with conservative surgery and chemotherapy","volume":"19","author":"T C McCormick","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"03","key":"ref20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1006\/gyno.1997.4801","article-title":"Advanced-stage small cell carcinoma of the ovary in pregnancy: long-term survival after surgical debulking and multiagent chemotherapy","volume":"66","author":"K Tewari","year":"1997","journal-title":"Gynecol Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"100576","DOI":"10.1016\/j.gore.2020.100576","article-title":"Successful pregnancy following chemotherapy in a survivor of small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): a case report and review of literature","volume":"32","author":"N Phoolcharoen","year":"2020","journal-title":"Gynecol Oncol Rep"},{"issue":"04","key":"ref22","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1016\/j.suronc.2011.06.002","article-title":"Cancer and pregnancy: a comprehensive review","volume":"20","author":"E Voulgaris","year":"2011","journal-title":"Surg Oncol"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejogrb.2012.10.026","article-title":"Cancer in pregnancy: a survey of current clinical practice","volume":"167","author":"S N Han","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"05","key":"ref24","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/jme.28.5.332-a","article-title":"Principles of Biomedical Ethics, 5th edn","volume":"28","author":"S Holm","year":"2002","journal-title":"J Med Ethics."},{"issue":"17","key":"ref25","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.3390\/cancers14174325","article-title":"Guidelines for cancer treatment during pregnancy: ethics-related content evolution and implications for clinicians","volume":"14","author":"A Linkeviciute","year":"2022","journal-title":"Cancers (Basel)"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"598508","DOI":"10.3389\/fonc.2020.598508","article-title":"Cancer during pregnancy: How to handle the bioethical dilemmas? A scoping review with paradigmatic cases-based analysis","volume":"10","author":"D Alpuim Costa","year":"2020","journal-title":"Front Oncol"}],"container-title":["American Journal of Perinatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2764-3698.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:19:08Z","timestamp":1767053948000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2764-3698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":19,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2025,11,11]]},"published-print":{"date-parts":[[2025,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2764-3698","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2157-6998","2157-7005"],"issn-type":[{"type":"print","value":"2157-6998"},{"type":"electronic","value":"2157-7005"}],"subject":[],"published-other":{"date-parts":[[2025,12,11]]},"published":{"date-parts":[[2025,10]]}}}